Home LiteratureArticle Details
PMID: 8609388 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 156 ·No. 8 ·1996-04-15 ·Pages 2716-22

Gibson S, August A, Kawakami Y, Kawakami T, Dupont B, Mills GB

Abstract

Functional T lymphocyte activation requires concurrent stimulation of the TCR complex and an accessory molecule, most frequently CD28. We have previously demonstrated that the TEC family tyrosine kinase EMT/ITK/TSK (EMT) is activated following cross-linking of CD28. We demonstrate herein that cross-linking of the CD3 component of the TCR complex also leads to EMT activation as indicated by a rapid and transient increase in EMT tyrosine phosphorylation and kinase activity in anti-EMT immunoprecipitates. However, although concurrent cross-linking of the TCR and CD28 results in a marked increase in production of the T cell growth factor IL-2, it does not result in a significant alteration in the magnitude or duration of EMT activation. Somatic cell mutants of the Jurkat T cell line, which lack the SRC family kinase LCK (JCaM1.6), fail to produce IL-2 when stimulated through the TCR complex. EMT activation, as evidenced by increased EMT tyrosine phosphorylation and EMT-associated kinase activity, was also greatly reduced following stimulation of the TCR in the JCaM1.6 Jurkat T cell mutants that lack LCK. In support of a role for LCK in EMT activation, reconstitution of the LCK-negative Jurkat T cell line by enforced expression of LCK restored TCR-mediated EMT activation. Taken together, the data indicate that the EMT tyrosine kinase is activated following cross-linking of the TCR, a process in which LCK likely plays an important role.

MeSH Terms
Antibodies, Monoclonal/pharmacology CD28 Antigens/physiology Cross-Linking Reagents Drug Synergism Enzyme Activation/immunology Humans Lymphocyte Specific Protein Tyrosine Kinase p56(lck) Lymphoma, T-Cell/enzymology,immunology Phosphorylation Protein-Tyrosine Kinases/immunology,physiology Receptors, Antigen, T-Cell/immunology,metabolism,physiology Signal Transduction/immunology T-Lymphocytes/enzymology Tumor Cells, Cultured src-Family Kinases/metabolism,physiology
Chemicals
Antibodies, Monoclonal CD28 Antigens Cross-Linking Reagents Receptors, Antigen, T-Cell Protein-Tyrosine Kinases Lymphocyte Specific Protein Tyrosine Kinase p56(lck) emt protein-tyrosine kinase src-Family Kinases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Gibson S
Molecular Oncology, Division of Medicine, University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
August A
Kawakami Y
Kawakami T
Dupont B
Mills G B
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1996-04-15
Pages
2716-22
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NCI NIH HHS · CA08748 · United States
NCI NIH HHS · CA22507 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]